Everett Cunningham
President and CEO, Director at Quanterix Corp (QTRX) since January 2026
Everett Cunningham has filed 23 insider reports with the SEC since November 2021, as director at Arvinas, Inc. (ARVN), president and CEO and director at Quanterix Corp (QTRX) and SVP and chief Commercial Officer at Illumina, Inc. (ILMN) and at 1 more company. Everett Cunningham made no open-market purchases or sales in the last 12 months. The latest filing, on June 26, 2026, reports grant or award at Arvinas, Inc. (ARVN).
- Filings
- 23
- Companies
- 4
- Bought on market
- None
- Sold on market
- $2.06M
Companies where Everett Cunningham is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas, Inc. | Directorsince December 2022 | 41,572 | $6.41 | Jun 26, 2026 | |||
| QTRX Quanterix Corp | President and CEO, Directorsince January 2026 | $2.895 | Jan 21, 2026 | ||||
| ILMN Illumina, Inc. | SVP, Chief Commercial Officersince June 2024 | 41,942 | $213.13 | Jul 8, 2025 | |||
| EXAS Exact Sciences Corp | Chief Commercial Officersince November 2021 | 47,042 | $2.06M | May 2, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 24, 2026ARVNDirector Cunningham Everett was granted 15,527 shares, increasing direct ownership by 60% to 41,572 unitsForm 4Grant or award
- Jan 19, 2026QTRXSEC Form 4 filed by President and CEO Cunningham EverettForm 4Grant or award
- Jan 19, 2026QTRXEverett Cunningham became an insiderForm 3New insider
- Jul 5, 2025ILMNSVP, Chief Commercial Officer Cunningham Everett covered exercise/tax liability with 4,248 shares, decreasing direct ownership by 9% to 41,942 unitsForm 4Shares withheld for taxes or exercise price
- Jun 25, 2025ARVNDirector Cunningham Everett was granted 16,025 shares, increasing direct ownership by 160% to 26,045 unitsForm 4Grant or award
- Mar 5, 2025ILMNSVP, Chief Commercial Officer Cunningham Everett was granted 9,103 shares, increasing direct ownership by 25% to 46,190 unitsForm 4Grant or award
- Jul 5, 2024ILMNSVP, Chief Commercial Officer Cunningham Everett was granted 36,860 sharesForm 4Grant or award
- Jun 10, 2024ILMNNew insider Cunningham Everett claimed ownership of 4,650 sharesForm 3New insider
- May 29, 2024ARVNCunningham Everett was granted 5,899 shares, increasing direct ownership by 143% to 10,020 unitsForm 4Grant or award
- May 1, 2024-$8,180EXASCunningham Everett was granted 999 shares and sold $8,180 worth of shares (136 units at $60.15), increasing direct ownership by 2% to 47,042 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Mar 1, 2024-$143KEXASCunningham Everett converted options into 5,291 shares and sold $143,080 worth of shares (2,412 units at $59.32), increasing direct ownership by 7% to 46,179 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 27, 2024-$208KEXASCunningham Everett converted options into 7,678 shares and sold $207,535 worth of shares (3,648 units at $56.89), increasing direct ownership by 10% to 43,300 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 22, 2024-$80.7KEXASCunningham Everett was granted 2,711 shares and sold $80,703 worth of shares (1,350 units at $59.78), increasing direct ownership by 4% to 39,270 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Oct 12, 2023-$865KEXASCunningham Everett was granted 709 shares, converted options into 27,504 shares and sold $864,835 worth of shares (13,007 units at $66.49), increasing direct ownership by 67% to 37,909 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 15, 2023ARVNSEC Form 4 filed by Cunningham EverettForm 4Grant or award
- Mar 1, 2023-$225KEXASSEC Form 4: Cunningham Everett sold $224,972 worth of shares (3,628 units at $62.01) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 22,703 units to cover taxesForm 4Open-market sale10b5-1 plan
- Feb 27, 2023EXASSEC Form 4: Cunningham Everett converted options into 7,677 shares, increasing direct ownership by 41% to 26,331 unitsForm 4Exercise or conversion of a derivative
- Feb 24, 2023EXASSEC Form 4 filed by Cunningham EverettForm 4Grant or award
- Dec 15, 2022ARVNSEC Form 4 filed by Cunningham EverettForm 4Grant or award
- Dec 15, 2022ARVNEverett Cunningham became an insiderForm 3New insider
- Oct 12, 2022-$529KEXASSEC Form 4: Cunningham Everett was granted 520 shares, converted options into 35,006 shares and sold $529,275 worth of shares (16,872 units at $31.37) as part of a pre-agreed trading plan to cover withholding taxForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 25, 2022EXASSEC Form 4 filed by Cunningham EverettForm 4Grant or award
- Nov 1, 2021EXASEverett Cunningham became an insiderForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Everett Cunningham.
Compare Everett Cunningham with
- Everett Cunningham vs Jeffrey Thomas Elliott2 shared
- Everett Cunningham vs Keith A. Meister1 shared
- Everett Cunningham vs Scott B. Ullem1 shared
- Everett Cunningham vs Ivana Magovcevic-Liebisch1 shared
- Everett Cunningham vs Scott Mendel1 shared
- Everett Cunningham vs William P Donnelly1 shared
Other insiders at the same companies
- Keith A. MeisterILMN
- Scott B. UllemILMN
- Ivana Magovcevic-LiebischQTRX
- Scott MendelQTRX
- William P DonnellyQTRX
- Sunil AgarwalARVN
- James Edward Gute Jr.QTRX
- Michael Francis MillerQTRX
- Julie Ann ColettiILMN
- Steven BarnardILMN
- Noah BerkowitzARVN
- Christensen Jakob WedelILMN
- Michael C SullivanILMN
- Scott M DaviesILMN
- Jason F. FaesslerQTRX
Questions about Everett Cunningham
- What is Everett Cunningham's role at Quanterix Corp?
- Everett Cunningham reports to the SEC as president and CEO and director at Quanterix Corp (QTRX), according to the latest filing on January 21, 2026. Everett Cunningham has also filed as director at Arvinas, Inc. (ARVN), SVP and chief Commercial Officer at Illumina, Inc. (ILMN) and chief Commercial Officer at Exact Sciences Corp (EXAS).
- How many shares does Everett Cunningham own?
- After the latest filing that states it, Everett Cunningham directly owned 41,572 shares of Arvinas, Inc. (ARVN), 41,942 shares of Illumina, Inc. (ILMN) and 47,042 shares of Exact Sciences Corp (EXAS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Everett Cunningham bought or sold stock recently?
- The most recent open-market sale was on May 1, 2024: sold 136 shares of Exact Sciences Corp (EXAS) for $8,180 at an average of $60.15.
- How do I get alerts when Everett Cunningham files?
- Follow Everett Cunningham on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Everett Cunningham (SEC CIK 0001564777). Totals count each trade once, skipping amendments whose original is on file, from Nov 5, 2021 on. View on SEC EDGAR